Myoscience
Fremont, US · Delaware corporation · 2 known investors
Founders & leadership
TH
Tracey HenryGeneral Manager
JS
John SupanInterim CFO
JA
John AllisonExecutive
JC
Justin ChicklesExecutive
PO
Peter OsborneExecutive
TH
Tracy HenryExecutive
JD
Jesse D. RosenExecutive
JG
Jeffrey GoldExecutive
Board
JP
Jan PensaertBoard director
RM
Rudi MarienBoard director
RM
Richard M. FerrariBoard director
RL
Remmert LaanBoard director
Investors · 2
Reported raises · per SEC filings
Form D private placements$58.9M disclosed across 5 rounds · 2014–2018
▶$5MraisedNov 2018 · 4 investors · OtherRule 506(b)
▶$5MraisedNov 2018 · 4 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Brian FarleyDirector
- Jon SerbousekDirector
- Bernard CoulieDirector
- Jan PansaertDirector
- Anthony LandoDirector
- Sam Mawn-MahlauExecutive Officer
- Timothy StillExecutive Officer, Director
- Darnard GuillaumeDirector
- Amount sold
- $5M
- First sale
- Oct 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$30.9MraisedMar 2018 · 17 investors · OtherRule 506(b)
▶$30.9MraisedMar 2018 · 17 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Guillaume DarnardDirector
- Sam Mawn-MahlauExecutive Officer
- Anthony LandoDirector
- Bernard CoulieDirector
- Jon SerbousekDirector
- John SupanExecutive Officer
- Cary VanceExecutive Officer, Director
- Jan PensaertDirector
- Offering amount
- $40.9M
- Amount sold
- $30.9M
- First sale
- Mar 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$14MraisedOct 2017 · 2 investors · OtherRule 506(b)
▶$14MraisedOct 2017 · 2 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Jon SerbousekDirector
- Sam Mawn-MahlauExecutive Officer
- Guillaume DarnardDirector
- Cary VanceExecutive Officer
- Anthony LandoDirector
- Bernard CoulieDirector
- Jan PensaertDirector
- Offering amount
- $21M
- Amount sold
- $14M
- First sale
- Nov 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$556.2KraisedMar 2017 · 3 investors · OtherRule 506(b)
▶$556.2KraisedMar 2017 · 3 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Sam Mawn-MahlauExecutive Officer
- Jan PensaertDirector
- Rudi MarienDirector
- Anthony LandoDirector
- Tracey HenryExecutive Officer
- Bernard CoulieDirector
- John SupanExecutive Officer
- Jon SerbousekDirector
- Offering amount
- $556.2K
- Amount sold
- $556.2K
- First sale
- Mar 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$8.4MraisedSep 2014 · 28 investors · OtherRule 506(b)
▶$8.4MraisedSep 2014 · 28 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Richard M. FerrariExecutive Officer, Director
- Rudi MarienDirector
- Remmert LaanDirector
- John AllisonExecutive Officer
- Justin ChicklesExecutive Officer
- James HawkinsDirector
- Peter OsborneExecutive Officer
- Tracy HenryExecutive Officer
- Edwin SnapeDirector
- Jesse D. RosenExecutive Officer
- Jeffrey GoldExecutive Officer
- Offering amount
- $11.5M
- Amount sold
- $8.4M
- First sale
- Jul 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who are Myoscience's investors?
- Myoscience's investors include Accuitive Medical Ventures, De Novo Ventures.
- How much funding has Myoscience raised?
- Myoscience has disclosed $58.9M raised across 5 rounds.
- Where is Myoscience headquartered?
- Myoscience is headquartered in Fremont, US.